Tall Women Beware

Extra inches may mean a higher chance of getting ovarian cancer.

By | April 5, 2012

Kathleen Zarubin" > Flickr, Kathleen Zarubin

FLICKR, KATHLEEN ZARUBIN

According to a new meta-analysis of previous studies, taller women have a slightly higher risk of getting ovarian cancer than shorter women, reported BBC News. The study, published Tuesday (April 3) in PLoS Medicine,  supports the conclusions of similar analyses that suggest taller women may be at a higher risk of a variety of cancer types. The new study analyzed data from over 25,000 women across 14 countries and saw an increased frequency of the disease in taller women, as well as those with a larger body-mass index.

"By bringing together the worldwide evidence, it became clear that height is a risk factor," lead researcher Valerie Beral of Oxford University told the BBC. Although the increase is significant, “the absolute risk difference is small. The shorter woman will have a lifetime risk of about 16-in-a-1000, which increases to 20-in-a-1000 for the taller woman,” Paul Pharoah, an epidemiologist at the University of Cambridge told the BBC.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech